Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors

by Lualdi, Manuela, Cavalleri, Adalberto, Battaglia, Luigi, Colombo, Ambrogio, Garrone, Giulia, Morelli, Daniele, Pignoli, Emanuele, Sottotetti, Elisa, Leo, Ermanno
Published in BMC Cancer (2018)

Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience

by Sepe, Pierangela, Verzoni, Elena, Miodini, Patrizia, Claps, Melanie, Ratta, Raffaele, Martinetti, Antonia, Mennitto, Roberta, Sottotetti, Elisa, Procopio, Giuseppe, Cappelletti, Vera, Daidone, Maria Grazia
Published in Cancers (Basel) (2019)

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

by Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Published 2014

Circulating microRNAs and PD-L1 tumor expression are associated with survival in advanced NSCLC patients treated with immunotherapy: a prospective study

by Boeri, Mattia, Milione, Massimo, Proto, Claudia, Signorelli, Diego, Lo Russo, Giuseppe, Galeone, Carlotta, Verri, Carla, Mensah, Mavis, Centonze, Giovanni, Martinetti, Antonia, Sottotetti, Elisa, Pastorino, Ugo, Garassino, Marina C., Sozzi, Gabriella
Published in Clin Cancer Res (2019)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase

by Falvella, Felicia Stefania, Caporale, Marta, Cheli, Stefania, Martinetti, Antonia, Berenato, Rosa, Maggi, Claudia, Niger, Monica, Ricchini, Francesca, Bossi, Ilaria, Di Bartolomeo, Maria, Sottotetti, Elisa, Bernardi, Francesca Futura, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Int J Mol Sci (2015)

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

by Falvella, Felicia Stefania, Cheli, Stefania, Martinetti, Antonia, Mazzali, Cristina, Iacovelli, Roberto, Maggi, Claudia, Gariboldi, Manuela, Pierotti, Marco Alessandro, Di Bartolomeo, Maria, Sottotetti, Elisa, Mennitto, Roberta, Bossi, Ilaria, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Br J Clin Pharmacol (2015)